4163.SR Stock — Price, Charts & Analysis

Al-Dawaa Medical Services Company (4163.SR) has a trailing P/E of 18.05x and a forward P/E of 7.43x. This places 4163.SR in a moderate earnings multiple territory based on the valuation data currently available on Worldtickers.

4163.SR trades with 18.05x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether 4163.SR looks overvalued or undervalued.

4163.SR's P/E of 18.05x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

4163.SR's trailing EPS is SAR 2.15 and forward EPS is SAR 5.22. Reported earnings growth is -65.00%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Al-Dawaa Medical Services Company generated for each share. 4163.SR's trailing EPS is SAR 2.15, and investors usually prefer EPS that is positive and growing over time.

Al-Dawaa Medical Services Company has a market cap of SAR 3.30B, making 4163.SR a mid-cap stock based on the current market value shown on Worldtickers.

4163.SR's latest stock price on Worldtickers is SAR 38.80. The latest move is SAR 0.38 or 0.99%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

4163.SR's quote includes a latest price of SAR 38.80. The market open is SAR 38.42. Previous close is SAR 38.42. The intraday range is SAR 38.24 to SAR 38.90.

4163.SR is up in the latest quote, with a move of SAR 0.38 or 0.99%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

4163.SR generated SAR 6.57B in trailing revenue. Revenue growth is -2.90%, which helps show whether demand is expanding or slowing.

4163.SR's revenue growth is -2.90%, which is a negative demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, 4163.SR shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is SAR 182.53M.

Gross margin is 34.63%. Margins show how efficiently Al-Dawaa Medical Services Company turns revenue into profit.

Al-Dawaa Medical Services Company carries SAR 2.39B and holds SAR 104.02M in cash.

4163.SR holds SAR 104.02M on its balance sheet.

4163.SR's book value per share is SAR 15.86.

Yes, Al-Dawaa Medical Services Company pays a dividend of SAR 3.15 per share annually. The dividend yield is 812.00%. The payout ratio is 146.51%.

4163.SR's dividend yield is 812.00%. Its payout ratio is 146.51%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for 4163.SR. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Al-Dawaa Medical Services Company's investor relations materials.

Institutions hold 2.39% of 4163.SR shares. Insiders hold 68.81% of shares. Ownership mix helps investors understand how much of Al-Dawaa Medical Services Company is held by professional investors and company insiders.

4163.SR has 85M shares outstanding. Float shares are 25.63M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for 4163.SR, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for 4163.SR is SAR 5.22. Earnings growth is -65.00%. Revenue growth is -2.90%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

4163.SR's trailing EPS is SAR 2.15. Forward EPS is SAR 5.22. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

4163.SR is in the Healthcare sector. Its earnings multiple is 18.05x. Its latest displayed growth metric is -2.90%. Compare these figures with sector peers before deciding whether Al-Dawaa Medical Services Company is stronger or weaker than average.

4163.SR trades at SAR 38.80. The stock trades at 18.05x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Al-Dawaa Medical Services Company's fundamentals.

4163.SR risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is -0.01, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

4163.SR should be compared with companies in Pharmaceutical Retailers. Its earnings multiple is 18.05x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Al-Dawaa Medical Services Company (4163.SR) operates in Healthcare, specifically Pharmaceutical Retailers. Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia and Kingdom of Bahrain. The company offers medicines, perfumes, cosmetics, beauty tools, and other pharmaceutical products; and transportation and logistics services. It is also involved in online wholesale of pharmaceutical products, pharmaceutical agents, wholesale of pharmaceutical goods, related pharmacy activities, pharmaceutical warehousing activities, retail

4163.SR trades on Saudi. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

4163.SR stock is priced in SAR on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Al-Dawaa Medical Services Company's official website listed on Worldtickers is www.al-dawaa.com.sa. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Al-Dawaa Medical Services Company is headquartered in Al Khobar, Saudi Arabia. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

4163.SR is in the Healthcare sector and the Pharmaceutical Retailers industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

4163.SR has traded between SAR 37.50 and SAR 68.95 over the past 52 weeks. At SAR 38.80, it is 43.73% below the high and 3.47% above the low. The 52-week range helps gauge long-term price momentum.

4163.SR is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is SAR 41.52 and its 200-day moving average is SAR 48.81.

4163.SR's RSI is 37.95. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

4163.SR's latest RSI reading is 37.95, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for 4163.SR is near SAR 37.50. Key resistance is near SAR 41.60. Breaks above resistance or below support can change the short-term technical setup.

4163.SR's nearest reported support level is SAR 37.50. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

4163.SR's nearest reported resistance level is SAR 41.60. A breakout above resistance can improve momentum, especially when volume confirms the move.

4163.SR trades about 128.99K shares daily on average. The latest displayed volume is 66.6K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

4163.SR's MACD is 0.04, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

4163.SR is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 37.95 (neutral). MACD is bullish. Nearest support is around SAR 37.50. Resistance is around SAR 41.60. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is SAR 39.63 (-2.09% from price). MA50 is SAR 41.52 (-6.54% from price). MA200 is SAR 48.81 (-20.50% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. 4163.SR's MA20 is SAR 39.63. MA50 is SAR 41.52. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

4163.SR's pivot is near SAR 38.41. Support is near SAR 37.50. Resistance is near SAR 41.60. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next upper resistance zone is near SAR 40.29. These levels help define risk and possible follow-through zones after a breakout or breakdown.

4163.SR's Bollinger range is roughly SAR 37.30 to SAR 41.96. Band width is near 11.76%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

4163.SR's ATR-based typical daily range is about 1.64%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 66.6K shares. Average volume is about 128.99K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

4163.SR's all-time high shown on Worldtickers is SAR 121.60. Its all-time low is SAR 37.50. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

4163.SR has a beta of -0.01, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.